Health · Greece

Innovative drugs increase economic benefit by 430 euros and improve patient access

1 sourceFirst reported 11 days agoUpdated 11 days ago

AI summary: catch up in 20 seconds

Innovative medications could provide an economic benefit of €430, according to a new study conducted across 29 European countries.
The findings suggest that innovative drugs are often perceived as a cost burden within healthcare systems globally.
The study emphasizes the need for incentives to facilitate the quicker arrival and access of these medications for patients.
Health systems are encouraged to reconsider their approach to the funding and integration of innovative pharmaceuticals.
Overall, the research highlights the potential economic advantages of investing in innovative medical treatments.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

Sign in to join the discussion.

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

Innovative medications could provide an economic benefit of €430, according to a new study conducted across 29 European countries.
The findings suggest that innovative drugs are often perceived as a cost burden within healthcare systems globally.
The study emphasizes the need for incentives to facilitate the quicker arrival and access of these medications for patients.
Health systems are encouraged to reconsider their approach to the funding and integration of innovative pharmaceuticals.
Overall, the research highlights the potential economic advantages of investing in innovative medical treatments.

Generated by AI from the 1 sources below · always verify with the originals